PHARMACOR INC has a total of 32 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are HARMAN FINOCHEM LTD, BIKAM PHARMACEUTICALS INC and ESWARAIAH SAJJA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 6 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Acyclic or carbocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Medical preparations | |
#5 | Peptides | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sauve Gilles | 30 |
#2 | Yelle Jocelyn | 19 |
#3 | Stranix Brent Richard | 19 |
#4 | Bouzide Abderrahim | 19 |
#5 | Sevigny Guy | 8 |
#6 | Cote Alexandre | 7 |
#7 | Zhao Yongsen | 7 |
#8 | Berube Gervais | 7 |
#9 | Soucy Patrick | 7 |
#10 | Leberre Nicolas | 2 |
Publication | Filing date | Title |
---|---|---|
AU2003215469A1 | Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors | |
AU2003206588A1 | Urea derivatives as hiv aspartyl protease inhibitors | |
US6632816B1 | Aromatic derivatives as HIV aspartyl protease inhibitors | |
US6638921B1 | Pyridoxal-5-phosphate derivatives as HIV integrase inhibitors | |
US6528532B1 | Urea derivatives as HIV aspartyl protease inhibitors | |
US6506786B2 | HIV protease inhibitors based on amino acid derivatives | |
CA2321348A1 | Aromatic derivatives with hiv integrase inhibitory properties | |
US6362165B1 | Hydroxyphenyl derivatives with HIV integrase inhibitory properties | |
EP1165492A1 | Hydroxyphenyl derivatives with hiv integrase inhibitory properties | |
US6455587B1 | Amino acid derivatives as HIV aspartyl protease inhibitors | |
US6313177B1 | D-mannitol derivatives as HIV aspartyl protease inhibitors |